Dr Pradeep Reddy'S Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 50.12%
- Profit Growth -112.42%
- Ebitda 411.49%
- Net Worth -89.80%
- Total Assets 94.03%
About Dr Pradeep Reddy'S Laboratories
Dr Pradeep Reddy's Laboratories Private Limited (DPRLPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 September 2015 (Nine years and five months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manikyam Potlapadu and Lakshmieshwari Potlapadu serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900TG2015PTC100893
- Company No.
100893
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2015
- Date of AGM
28 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Dr Pradeep Reddy'S Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manikyam Potlapadu  | Director | 15-Feb-2018 | Current |
| Lakshmieshwari Potlapadu | Director | 24-Sep-2015 | Current |
Financial Performance of Dr Pradeep Reddy'S Laboratories.
Dr Pradeep Reddy'S Laboratories Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 50.12% increase. The company also saw a substantial fall in profitability, with a 112.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Pradeep Reddy'S Laboratories?
In 2019, Dr Pradeep Reddy'S Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Victory Seeds Private LimitedManikyam Potlapadu and Lakshmieshwari Potlapadu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Pradeep Reddy'S Laboratories?
Unlock and access historical data on people associated with Dr Pradeep Reddy'S Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Pradeep Reddy'S Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Pradeep Reddy'S Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
